Loading...

ATYR ATYR PHARMA INC Capital Structure Changes 8-K Filing

TYR

TYR

ATYR PHARMA INC

(ATYR)

2024 8-K

Show Summary

Show Summary

Financial Statements

Stock Option Plans

Financial Results

Share Offering Update

Director Appointment

Financial Results

Financial Results

Clinical Trial Enrollment C...

Annual Meeting Approval

Earnings Reports

Earnings Reports

Financial Results Announcement

Investor Conferences

Presentation of Study Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Disinvestment of Assets

Financial Results Announcement

Public Offering

Phase 3 Study Milestone

External Links:

aTyr Pharma has amended its agreement with Jefferies LLC to allow for the sale of additional shares of common stock, increasing the total offering amount to $65 million, with no obligation to sell any shares.

AI Assistant

ATYR PHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.